These markers concerned the coefficient of variance (CV) of the expression of CD36 and CD71 (both increased in MDS), the expression of CD71 (decreased), and the percentage of CD117+ erythroid precursors (decreased or increased). The gene discussed is KIT; the disease is myelodysplastic syndrome.